Clinical Trial Update: Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose study of SHR4640 in male subjects with high serum uric acid levels has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• SHR4640

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Gout, Hyperuricemia | Phase 1 | Status: COMPLETED